Artelo Biosciences Inc.

1.05
0.02 (1.45%)
At close: Mar 05, 2025, 3:59 PM
1.02
-2.86%
After-hours: Mar 05, 2025, 04:00 PM EST

Artelo Biosciences Balance Sheet Statement

Year FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
Cash & Equivalents 6.89M 6.63M 2.14M 4.42M 337.42K 572.77K 3.59K 17.03K 14.73K
Short-Term Investments 10.64M 3.44M n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments -1.5M n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets 3K 189K n/a n/a n/a n/a n/a n/a n/a
Receivables n/a n/a n/a 8.79K 22.13K n/a n/a n/a n/a
Inventory n/a n/a n/a -8.79K n/a n/a n/a n/a n/a
Other Current Assets 789K 252K 195.13K 18.62K 36.88K 1.5K n/a n/a n/a
Total Current Assets 18.32M 10.32M 2.34M 4.44M 396.44K 574.27K 3.59K 17.03K 14.73K
Property-Plant & Equipment 60K 90K 246.00 721.00 563.00 n/a n/a n/a n/a
Goodwill & Intangibles 2.04M 2.04M 2.04M 2.04M n/a n/a n/a n/a n/a
Total Long-Term Assets 2.1M 2.32M 2.04M 2.04M 563.00 n/a n/a n/a n/a
Total Assets 20.42M 12.63M 4.38M 6.48M 397K 574.27K 3.59K 17.03K 14.73K
Account Payables 905K 493K 490.22K 348.86K 529.27K 28.58K 12.94K n/a n/a
Deferred Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt 40K 28K n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities -852K -488K -478.26K 323.79K -526.57K -27.71K -8.49K 1.74K n/a
Total Current Liabilities 998K 526K 502.18K 1.02M 531.97K 29.44K 17.39K 1.74K n/a
Long-Term Debt 23K 67K n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities n/a n/a 490.22K 348.86K n/a n/a n/a n/a n/a
Total Long-Term Liabilities 23K 67K 490.22K 348.86K 529.27K 28.58K 12.94K n/a n/a
Total Liabilities 1.02M 593K 502.18K 1.02M 531.97K 29.44K 17.39K 1.74K n/a
Total Debt 63K 95K n/a n/a n/a n/a n/a n/a n/a
Common Stock 3K 25K 4.99K 3.35K 14K 11.33K 7.64K 7.64K 6K
Retained Earnings -31.02M -16.9M -9.47M -4.81M -2.64M -295.09K -60.2K -30.51K -15.27K
Comprehensive Income -254K 18K 63.76K -9.81K -12.28K 657.00 n/a n/a n/a
Shareholders Equity 19.4M 12.04M 3.87M 5.46M -134.97K 544.84K -13.8K 15.29K 14.73K
Total Investments 9.15M 3.44M n/a n/a n/a n/a n/a n/a n/a